These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus. Wang Z, Li K, Dong K, Xiao X, Zheng S. J Pediatr Hematol Oncol; 2015 Jan; 37(1):72-3. PubMed ID: 24309604 [No Abstract] [Full Text] [Related]
3. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma. Wang H, Guo X, Duan Y, Zheng B, Gao Y. Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213 [Abstract] [Full Text] [Related]
4. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants. Wang Y, Kong L, Sun B, Cui J, Shen W. J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003 [Abstract] [Full Text] [Related]
9. Bone kaposiform hemangioendothelioma: A rare entity dramatically improved by sirolimus. Boccara O, Dangien A, Fitoussi F, Ducou Le Pointe H, Coulomb L'Hermine A, Fraitag S, Lorrot M. J Paediatr Child Health; 2022 Sep; 58(9):1676-1679. PubMed ID: 35138010 [No Abstract] [Full Text] [Related]
10. Kaposiform haemangioendothelioma in a nine-year-old boy with Kasabach-Merritt phenomenon. Zhang G, Gao Y, Liu X. Br J Haematol; 2017 Oct; 179(1):9. PubMed ID: 28714059 [No Abstract] [Full Text] [Related]